Email ID
Password
Scrip   
Idera gets extension to Merck & Co deal but loses Novartis
27 November 2009
Simon Varcoe

An extension to Merck & Co and Idera Pharmaceuticals' toll-like receptor (TLR) research agreement failed to stop the latter company's share price from falling on November 25th after Novartis terminated its asthma and allergy research deal.

Novartis paid Idera $4 million up front in May...



Please Login to read the full article.
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36